LDN-212854是新型BMP抑制剂,对ALK2的IC50为1.3 nM,比对ALK1,ALK3,ALK4和ALK5的抑制性高2,66,1641和7135倍。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
LDN 212854
Dangerous GoodsCAS number:1432597-26-6 molecular formula:C25H22N6
overview
compound introduction
Specs
| Chinese alias | 5-(6-(4-(1-哌嗪基)苯基)吡唑并[1,5-a]嘧啶-3-基)喹啉 | ||
| English alias | SB19484 | BDBM102618 | CCG-268725 | LDN 212854 | C72696 | BCP08633 | 5-(6-(4-(1-Piperazinyl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | AS-16555 | BMP Inhibitor III | AKOS026750252 | EX-A425 | LDN 212854;LDN212854 | LDN212854 | LDN-212854 | NCGC00386 | ||
| CAS number | 1432597-26-6 | molecular formula | C25H22N6 |
| molecular weight | 406.48 g/mol | Exact mass | 10mM in DMSO |
| PSA | 58.400 Ų | logp | 3.300 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS06
Signal word:
Danger
Hazard Statement:
H301: 吞咽会中毒
Statement of Preventive Measures:
P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P301+P316: 如果吞咽:立即寻求紧急医疗救助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





